-
MEXIDOL® (Emoxipine) 125 mg, 50 coated tablets
$17.00
$22.00 -
ARPEFLU (Umifenovir) 100 mg, 20/30 caps
$24.00 – $33.00
Description
The instruction for medical use
of TANFLEKS medicine
the Trade name
of Tanflex
the International unlicensed
name Benzydamine Dosage Form Spray of Oral 0.15% Structure of 1 Ml of Spray contains
active agent – benzydamine a hydrochloride of 1.500 mg,
excipients: sodium bicarbonate, polysorbate 20, alcohol of 96%, water purified, glycerin, sodium saccharin, methylparahydroxybenzoate, essence mint.
The description
Transparent, colourless liquid with a mint smell
Pharmacological group
Other drugs for treatment of diseases of an oral cavity. Benzydamine.
The ATX A01AD02 code
the Pharmacological
Pharmacokinetics Absorption Later properties of oral use benzydamine is quickly absorbed from digestive system, and in 2-4 hours the maximum level in plasma is reached. The most important aspect of distribution of benzydamine on fabrics is its concentration in an inflammation zone.
Elimination
About 50% of benzydamine is removed in an invariable look by kidneys with a speed of 10% from a dose in the first 24 hours. The rest is metabolized, mainly, by N-oxide.
The pharmacodynamics
Benzydamine has the anti-inflammatory and anesthetizing effect by stabilization of a cellular membrane and inhibition of synthesis of prostaglandins.
Indications
It is intended for topical administration as anesthetic and anti-inflammatory treatment of an oral cavity and a throat.
It is applied to pain relief in traumatic states such as:
– the subsequent tonsilectomy or use of a nazogastralny tube,
– the dental
operations Route of administration and doses
Adult and elderly: on 4-8 squirts each 1.5-3 hours
to Children (6-12 years): on 4 squirts each 1.5-3 hours
to Children are younger than 6 years: on 4 kg of body weight 1.5-3 hours, at most 4 squirts
Side effects
According to manifestation frequency the side reactions are determined by 1 dispersion as it is very frequent (& gt, 1/10), is frequent (& gt, 1/100, & lt, 1/10), infrequently (& gt, 1/1000, & lt, 1/100), is rare (& ge, 1/10, 000 and & lt, 1/1000), is very rare (& lt, 1/10, 000), it is unknown (it is impossible to estimate on the available data).
A class of system bodies
Frequency
the By-effect
Disturbance from the immune system
Is unknown
Anaphylactic reaction which can be potentially life-threatening and reactions of hypersensitivity of ii
Disturbances from respiratory organs, a thorax and mediastinum
Very seldom
the Laryngospasm or a bronchospasm
Disturbances from digestive tract
Infrequently Oral numbness and burning sensation in i mouth
Disturbances from skin and hypodermic cellulose
Very seldom
urticaria, reaction of photosensitivity and rash
is unknown to Reaction of hypersensitivity which can be connected with an itching,
the Quincke’s edema
i) Was reported that the acute pain disappeared as a result of treatment continuation, however, if it remains, recommended to stop treatment.
ii) Metilparagidroksibenzoat can cause allergic reactions (perhaps long action).
Contraindications
– hypersensitivity to drug components
– during pregnancy and in the period of a lactation
– children’s age up to 3 years
Medicinal interactions
Data are absent
Special instructions
It is necessary to avoid hit of spray in eyes.
Drug contains methylparahydroxybenzoate which can cause allergic reactions (perhaps slowed down action).
Drug also contains propylene glycol which can cause irritation of skin.
Pregnancy and the period of a lactation
is not recommended to be applied during pregnancy and in the period of a lactation (only in need of appointment as the doctor).
The fertility
Is not present data of teratogenic impact in researches on animals.
Features of influence of medicine on ability of control of vehicles and works with potentially dangerous mechanisms
Drug does not affect ability to run motor transport and other activity requiring special attention.
The overdose
Intoxication is expected only in case of accidental reception of concentration of benzydamine (& gt, 300 mg)
Symptoms
– nausea, vomiting, an abdominal pain and irritation of a gullet
– dizziness, hallucinations, excitement, concern and irritability
Treatment: symptomatic treatment is performed.
The patient has to be under fixed observation, and it is necessary to render the supporting treatment. It is necessary to support adequate hydration.
The form of release and packing
On 15 ml or 30 ml of drug spill in the bottles from dark glass supplied with a spray with a protective cap. On 1 bottle together with the instruction for medical use in the state and Russian languages place in a cardboard box.
To Store storage conditions in the dry, protected from light place, at
a temperature not higher than 25 S. Hranit out of children’s reach!
3 years
not to apply a period of storage after the expiration date specified on packing!
Prescription status
Without prescription
the Producer / Packer
of ABDI IBRAHIM Istanbul, Turkey
the Owner of the registration certificate
of ABDI IBRAHIM Istanbul, Turkey
the Address of the organization accepting in the territory of the Republic of Kazakhstan claims from consumers on quality of products and responsible for post-registration observation of safety of medicine in the territory of the Republic of Kazakhstan
Abdi Ibrahim Global Pharm LLP, the Republic of Kazakhstan, the Almaty Region, the Iliysky area, Industrial zone 282, ph.: +7 (727) 356-11-00, 8-800-070-1100, the e-mail address:
Additional information
| Ingredient |
|---|
Reviews
There are no reviews yet.